• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

新型抗利什曼原虫药物系列的合成与活性

Synthesis and Activity of a New Series of Antileishmanial Agents.

作者信息

Kanwar Ankush, Eduful Benjamin J, Barbeto Linda, Carletti Bonomo Piero, Lemus Andrea, Vesely Brian A, Mutka Tina S, Azhari Ala, Kyle Dennis E, Leahy James W

机构信息

Department of Chemistry, University of South Florida, CHE 205, 4202 East Fowler Avenue, Tampa, Florida 33620, United States.

Department of Global Health, College of Public Health, University of South Florida, 3720 Spectrum Boulevard, Suite 304, Tampa, Florida 33612, United States.

出版信息

ACS Med Chem Lett. 2017 Jul 31;8(8):797-801. doi: 10.1021/acsmedchemlett.7b00039. eCollection 2017 Aug 10.

DOI:10.1021/acsmedchemlett.7b00039
PMID:28835791
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5554902/
Abstract

We have determined that tetrahydroindazoles such as show potent activity against , the causative agent of leishmaniasis. While the Hsp90 activity and anticancer properties of have previously been explored, we present here our efforts to optimize their activity against via the synthesis of novel analogues designed to probe the hydrophobic pocket of the protozoan Hsp90 orthologue, specifically through the auspices of functionalization of an amine embedded into the scaffold.

摘要

我们已经确定,诸如四氢吲唑类化合物对利什曼病的病原体 显示出强大的活性。虽然此前已经研究了 的热休克蛋白90(Hsp90)活性和抗癌特性,但我们在此展示了我们通过合成新型类似物来优化其对 的活性的努力,这些类似物旨在探测原生动物Hsp90同源物的疏水口袋,特别是通过对嵌入支架中的胺进行功能化来实现。

相似文献

1
Synthesis and Activity of a New Series of Antileishmanial Agents.新型抗利什曼原虫药物系列的合成与活性
ACS Med Chem Lett. 2017 Jul 31;8(8):797-801. doi: 10.1021/acsmedchemlett.7b00039. eCollection 2017 Aug 10.
2
Ribosome Profiling Reveals HSP90 Inhibitor Effects on Stage-Specific Protein Synthesis in .核糖体分析揭示了HSP90抑制剂对[具体对象]阶段特异性蛋白质合成的影响。
mSystems. 2018 Nov 20;3(6). doi: 10.1128/mSystems.00214-18. eCollection 2018 Nov-Dec.
3
Quantitative Proteomics Reveals that Hsp90 Inhibition Dynamically Regulates Global Protein Synthesis in Leishmania mexicana.定量蛋白质组学揭示热休克蛋白90抑制可动态调节墨西哥利什曼原虫的整体蛋白质合成。
mSystems. 2021 May 11;6(3):e00089-21. doi: 10.1128/mSystems.00089-21.
4
In vitro activity of new N-benzyl-1H-benzimidazol-2-amine derivatives against cutaneous, mucocutaneous and visceral Leishmania species.新型N-苄基-1H-苯并咪唑-2-胺衍生物对皮肤、黏膜皮肤和内脏利什曼原虫物种的体外活性。
Exp Parasitol. 2018 Jan;184:82-89. doi: 10.1016/j.exppara.2017.11.009. Epub 2017 Dec 1.
5
Synthesis and biological evaluation of trifluralin analogues as antileishmanial agents.合成及三氟拉林类似物的生物评价作为抗利什曼原虫药物。
Bioorg Med Chem. 2010 Jan 1;18(1):274-81. doi: 10.1016/j.bmc.2009.10.059. Epub 2009 Oct 31.
6
Repurposing Glyburide as Antileishmanial Agent to Fight Against Leishmaniasis.将格列本脲重新用作抗利什曼原虫药物以对抗利什曼病。
Protein Pept Lett. 2019;26(5):371-376. doi: 10.2174/0929866526666190301114012.
7
Probing O-substituted nifuroxazide analogues against Leishmania: Synthesis, in vitro efficacy, and hit/lead identification.探讨 O-取代的硝呋齐特类似物对利什曼原虫的作用:合成、体外疗效和命中/先导化合物鉴定。
Eur J Pharm Sci. 2022 Sep 1;176:106242. doi: 10.1016/j.ejps.2022.106242. Epub 2022 Jun 19.
8
Novel β-carboline-quinazolinone hybrids disrupt Leishmania donovani redox homeostasis and show promising antileishmanial activity.新型β-咔啉-喹唑啉酮杂合体破坏利什曼原虫的氧化还原平衡,并显示出有希望的抗利什曼原虫活性。
Biochem Pharmacol. 2017 Apr 1;129:26-42. doi: 10.1016/j.bcp.2016.12.012. Epub 2016 Dec 22.
9
Synthesis and Antileishmanial Activity of 1,2,4,5-Tetraoxanes against .合成及 1,2,4,5-四氧杂环戊烷类化合物对. 的抗利什曼原虫活性
Molecules. 2020 Jan 22;25(3):465. doi: 10.3390/molecules25030465.
10
Development of Leishmania donovani stably expressing DsRed for flow cytometry-based drug screening using chalcone thiazolyl-hydrazone as a new antileishmanial target.稳定表达 DsRed 的杜氏利什曼原虫的开发,用于基于流式细胞术的药物筛选,以查尔酮噻唑基腙为新的抗利什曼原虫靶点。
Int J Antimicrob Agents. 2016 Dec;48(6):695-702. doi: 10.1016/j.ijantimicag.2016.09.018. Epub 2016 Nov 2.

引用本文的文献

1
Spongian Diterpenoids Derived from the Antarctic Sponge Are Potent Inhibitors of the Parasite.源自南极海绵的海绵二萜类化合物是该寄生虫的强效抑制剂。
J Nat Prod. 2020 May 22;83(5):1553-1562. doi: 10.1021/acs.jnatprod.0c00025. Epub 2020 Apr 13.
2
A docking-based structural analysis of geldanamycin-derived inhibitor binding to human or Leishmania Hsp90.基于对接的格尔德霉素衍生抑制剂与人或利什曼原虫 HSP90 结合的结构分析。
Sci Rep. 2019 Oct 14;9(1):14756. doi: 10.1038/s41598-019-51239-0.

本文引用的文献

1
Tropical disease: A neglected cause.热带疾病:一个被忽视的病因。
Nature. 2016 May 12;533(7602):S68-9. doi: 10.1038/533S68a.
2
Targeting Hsp90 in Non-Cancerous Maladies.针对非癌性疾病中的热休克蛋白90
Curr Top Med Chem. 2016;16(25):2792-804. doi: 10.2174/1568026616666160413141753.
3
Exploring in vitro and in vivo Hsp90 inhibitors activity against human protozoan parasites.探索体外和体内热休克蛋白90(Hsp90)抑制剂对人体原生动物寄生虫的活性。
Bioorg Med Chem Lett. 2015 Feb 1;25(3):462-5. doi: 10.1016/j.bmcl.2014.12.048. Epub 2014 Dec 20.
4
Targeting Plasmodium falciparum Hsp90: Towards Reversing Antimalarial Resistance.靶向疟原虫热休克蛋白 90:逆转抗疟耐药。
Pathogens. 2013 Feb 4;2(1):33-54. doi: 10.3390/pathogens2010033.
5
Phase I dose-escalation studies of SNX-5422, an orally bioavailable heat shock protein 90 inhibitor, in patients with refractory solid tumours.SNX-5422 是一种口服生物可利用的热休克蛋白 90 抑制剂,在难治性实体瘤患者中的 I 期剂量递增研究。
Eur J Cancer. 2014 Nov;50(17):2897-904. doi: 10.1016/j.ejca.2014.07.017. Epub 2014 Sep 25.
6
Antileishmanial activity of a series of N²,N⁴-disubstituted quinazoline-2,4-diamines.一系列 N²,N⁴-二取代喹唑啉-2,4-二胺的抗利什曼原虫活性。
J Med Chem. 2014 Jun 26;57(12):5141-56. doi: 10.1021/jm5000408. Epub 2014 Jun 17.
7
The HSP90 inhibitor 17-AAG potentiates the antileishmanial activity of the ether lipid edelfosine.HSP90 抑制剂 17-AAG 增强了醚脂埃尔德福西林的抗利什曼原虫活性。
Acta Trop. 2014 Mar;131:32-6. doi: 10.1016/j.actatropica.2013.11.018. Epub 2013 Dec 1.
8
Phase I trial of the HSP90 inhibitor PF-04929113 (SNX5422) in adult patients with recurrent, refractory hematologic malignancies.PF-04929113(SNX5422)在复发/难治性血液系统恶性肿瘤成人患者中的 I 期临床试验。
Clin Lymphoma Myeloma Leuk. 2013 Aug;13(4):385-91. doi: 10.1016/j.clml.2013.03.010. Epub 2013 Jun 10.
9
Potent antitrypanosomal activities of heat shock protein 90 inhibitors in vitro and in vivo.热休克蛋白 90 抑制剂在体外和体内的强效抗锥虫活性。
J Infect Dis. 2013 Aug 1;208(3):489-99. doi: 10.1093/infdis/jit179. Epub 2013 Apr 22.
10
An image-based high-content screening assay for compounds targeting intracellular Leishmania donovani amastigotes in human macrophages.基于图像的高通量筛选检测方法,用于检测针对人巨噬细胞内利什曼原虫无鞭毛体的化合物。
PLoS Negl Trop Dis. 2012;6(6):e1671. doi: 10.1371/journal.pntd.0001671. Epub 2012 Jun 12.